ClinicalTrials.Veeva

Menu

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

A

Alexandria University

Status

Enrolling

Conditions

Tinea Capitis

Treatments

Drug: Itraconazole (ITZ)

Study type

Interventional

Funder types

Other

Identifiers

NCT07184203
0108853

Details and patient eligibility

About

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Enrollment

120 estimated patients

Sex

All

Ages

5 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Tinea capitis patients with ages ranging from 5 to 18 year

Exclusion criteria

  • Patients with contraindications to itraconazole
  • Patients with associated scalp disease.
  • Patients weighing less than 20 Kg.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Group A will receive itraconazole continuous daily regimen
Active Comparator group
Treatment:
Drug: Itraconazole (ITZ)
Group B will receive itraconazole pulse regimen
Active Comparator group
Treatment:
Drug: Itraconazole (ITZ)

Trial contacts and locations

1

Loading...

Central trial contact

Marina K Aioub

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems